The Biodefence Market Report 2023-2033: This report will prove invaluable to leading firms striving for new revenue pockets if they wish to better understand the industry and its underlying dynamics. It will be useful for companies that would like to expand into different industries or to expand their existing operations in a new region.
Increasing R&D Investments in Developed Countries
Growing R&D investments enable pharmaceutical and biopharmaceutical companies to manufacture superior quality and technologically advanced bio-threat detection devices that should significantly impact the industry growth. Furthermore, European government also supports the R&D activities to manufacture vaccines against various diseases such as anthrax, small pox and botulism in large batches to fight infections and prevent the spread of endemic diseases. Bioterrorism attacks lead to deaths and may weaken the economy hence, government funds various pharmaceutical as well as biopharmaceutical companies that will elevate the industry growth in foreseeable future.
Increasing Awareness Regarding Bioterrorism Attacks to Propel Industry Growth
Increasing awareness regarding bioterrorism attacks in developed as well as underdeveloped economies will significantly fuel the biodefence market growth over the forecast period. Owing to the advent of internet and growing adoption of social media, news about the biological warfare in any part of the world can spread across the globe. It can cause anxiety to people located faraway and can greatly impact trade and travel. Governments in the developing countries such as Japan and India plan public awareness campaigns to raise public awareness about bioterrorism attacks. Such preventive measures undertaken by the government to combat various endemic diseases will boost industry growth in the foreseeable future.
Low Government Funding in Underdeveloped Regions Likely to Challenge Market Growth
Minimal government intervention and low R&D funding in underdeveloped regions will impede the biodefence market growth over the forecast period. Furthermore, due to poor economic development, governments and regulatory authorities in countries such as Mexico and Brazil are unable to make significant investments to promote the use of biothreat detection devices. There is a lack of awareness in developing regions about the availability of technologically advanced biothreat detection devices. Additionally, there is no established regulatory framework for biodefence devices and vaccines in underdeveloped economies. Key players that operate in the biodefence industry find it difficult to enter these countries due to changing trade policies. As a result, the distribution of tools and vaccinations used to combat bioterrorism is low in emerging regions which may hamper the Biodefence market growth.
What Questions Should You Ask before Buying a Market Research Report?
How is the Biodefence Market evolving?
What is driving and restraining the Biodefence Market?
How will each Biodefence submarket grow over the forecast period and how much revenue will these submarkets account for in 2033?
How will the market shares for each Biodefence submarket develop from 2023 to 2033?
What will be the main driver for the overall market from 2023 to 2033?
Will leading Biodefence Markets broadly follow the macroeconomic dynamics, or will individual national markets outperform others?
How will the market shares of the national markets change by 2033 and which geographical region will lead the market in 2033?
Who are the leading players and what are their prospects over the forecast period?
What are the Biodefence development projects for these leading companies?
How will the industry evolve during the period between 2023 and 2033? What are the implications of Biodefence development projects taking place now and over the next 10 years?
Is there a greater need for product commercialisation to further scale the Biodefence Market?
Where is the Biodefence Market heading and how can you ensure you are at the forefront of the market?
What are the best investment options for new product and service lines?
What are the key prospects for moving companies into a new growth path and C-suite?
You need to discover how this will impact the Biodefence Market today, and over the next 10 years:
Our 197-page report provides 112 tables and 107 charts/graphs exclusively to you.
The report highlights key lucrative areas in the industry so you can target them - NOW.
It contains in-depth analysis of global, regional and national sales and growth.
It highlights for you the key successful trends, changes and revenue projections made by your competitors.
This report tells you TODAY how the Biodefence Market will develop in the next 10 years, and in line with the variations in COVID-19 economic recession and bounce. This market is more critical now than at any point over the last 10 years.
Forecasts to 2033 and other analyses reveal commercial prospects
In addition to revenue forecasting to 2033, the new study provides you with recent results, growth rates, and market shares.
You will find original analyses, with business outlooks and developments.
Discover qualitative analyses (including market dynamics, drivers, opportunities, restraints and challenges), cost structure, impact of rising prices of bio-threat detection devices and recent developments.
This report includes data analysis and invaluable insight into how COVID-19 will affect the industry and your company. Four COVID-19 recovery patterns and their impact, namely, “V”, “L”, “W” and “U” are discussed in this report.
Segments Covered in the Report
By Product
Vaccines
Anthrax
Small Pox
Botulism
Others
Biothreat detection devices
Assays and reagents
Detectors
Identifiers
Samplers
In addition to the revenue predictions for the overall world market and segments, you will also find revenue forecasts for five regional and 16 leading national markets:
North America
U.S.
Canada
Europe
Germany
UK
France
Spain
Italy
Rest of Europe
Asia Pacific
China
Japan
India
Australia
South Korea
Rest of Asia Pacific
Latin America
Brazil
Mexico
Rest of Latin America
MEA
GCC
South Africa
Rest of MEA
The report also includes profiles and for some of the leading companies in the Biodefence Market, 2023 to 2033, with a focus on this segment of these companies’ operations.
Leading companies and the potential for market growth
Alexeter Technologies, LLC,
Altimmune
Achaogen, Inc.
Alnylam Pharmaceuticals
ANP Technology
Bavarian Nordic
BBI Detection
Biofire Defense (bioMerieux SA)
Biosearch Technologies
Bruker
Dynport Vaccine Company
Electronic Sensor Technology Inc.
Elusys Therapeutics
Emergent BioSolutions Inc.
Ichor Medical
NanoLogix
New Horizons Diagnostic Corporation
PositiveID Corporation
Research International
SIGA Technologies, Inc.
Statera Biopharma (Cleveland Biolabs)
Smith’s Detection
Synexis Systems
Overall world revenue for Biodefence Market, 2023 to 2033 in terms of value the market will surpass US$15,922 million in 2023, this work calculates. We predict strong revenue growth through to 2033. this work identifies which organizations hold the greatest potential. Discover their capabilities, progress, and commercial prospects, helping you stay ahead.
How will the Biodefence Market, 2023 to 2033 report help you?
In summary, this 197-page report provides you with the following knowledge:
Revenue forecasts to 2033 for Biodefence Market, 2023 to 2033 Market, with forecasts for Type of Product, each forecast at a global and regional level - discover the industry’s prospects, finding the most lucrative places for investments and revenues.
Revenue forecasts to 2033 for five regional and 16 key national markets - See forecasts for the Biodefence Market, 2023 to 2033 market in North America, Europe, Asia-Pacific and Latin America and Middle East and Africa. Also forecasted is the market in the US, Canada, Mexico, Brazil, Germany, France, UK, Italy, China, India, Japan, and Australia among other prominent economies.
Prospects for established firms and those seeking to enter the market - including company profiles of the major companies involved in the Biodefence Market, 2023 to 2033.
Find quantitative and qualitative analyses with independent predictions. Receive information that only this report contains, staying informed with invaluable business intelligence.
Information found nowhere else
With this new report, you are less likely to fall behind in knowledge or miss out on opportunities. See how this work could benefit your research, analyses, and decisions. The study is for everybody needing commercial analyses for the Biodefence Market, 2023 to 2033, market-leading companies. You will find data, trends and predictions.
Table of Contents
1 Report Overview
1.1 Objectives of the Study 1.2 Introduction to Biodefence Market 1.3 What This Report Delivers 1.4 Why You Should Read This Report 1.5 Key Questions Answered by This Analytical Report 1.6 Who is This Report for? 1.7 Methodology 1.7.1 Market Definitions 1.7.2 Market Evaluation & Forecasting Methodology 1.7.3 Data Validation 1.7.3.1 Primary Research 1.7.3.2 Secondary Research 1.8 Frequently Asked Questions (FAQs) 1.9 Associated Reports 1.10 About
2 Executive Summary
3 Market Overview
3.1 Key Findings 3.2 Market Dynamics 3.2.1 Market Driving Factors 3.2.1.1 Increasing R&D investments by the government 3.2.1.2 Favourable government initiatives in emerging economies 3.2.1.3 Technological developments in biotechnology sector in the developed countries 3.2.2 Market Restraining Factors 3.2.2.1 Low R&D funding in underdeveloped regions 3.2.3 Market Opportunities 3.2.3.1 Increasing list of bio-threat agents 3.2.3.2 Development of advanced biotechnology products 3.3 COVID-19 Impact Analysis 3.4 Porter’s Five Forces Analysis 3.4.1 Bargaining Power of Suppliers 3.4.2 Bargaining Power of Buyers 3.4.3 Competitive Rivalry 3.4.4 Threat from Substitutes 3.4.5 Threat of New Entrants 3.5 PEST Analysis
4 Biodefence Market Analysis by Product
4.1 Key Findings 4.2 Product Segment: Market Attractiveness Index 4.3 Biodefence Market Size Estimation and Forecast by Product 4.4 Vaccines 4.4.1 Anthrax 4.4.1.1 Market Size by Region, 2023-2033 (US$ Mn) 4.4.1.2 Market Share by Region, 2023 & 2033 (%) 4.4.2 Small Pox 4.4.2.1 Market Size by Region, 2023-2033 (US$ Mn) 4.4.2.2 Market Share by Region, 2023 & 2033 (%) 4.4.3 Botulism 4.4.3.1 Market Size by Region, 2023-2033 (US$ Mn) 4.4.3.2 Market Share by Region, 2023 & 2033 (%) 4.4.4 Others 4.4.4.1 Market Size by Region, 2023-2033 (US$ Mn) 4.4.4.2 Market Share by Region, 2023 & 2033 (%) 4.5 Biothreat detection devices 4.5.1 Assays and reagents 4.5.1.1 Market Size by Region, 2023-2033 (US$ Mn) 4.5.1.2 Market Share by Region, 2023 & 2033 (%) 4.5.2 Detectors 4.5.2.1 Market Size by Region, 2023-2033 (US$ Mn) 4.5.2.2 Market Share by Region, 2023 & 2033 (%) 4.5.3 Identifiers 4.5.3.1 Market Size by Region, 2023-2033 (US$ Mn) 4.5.3.2 Market Share by Region, 2023 & 2033 (%) 4.5.4 Samplers 4.5.4.1 Market Size by Region, 2023-2033 (US$ Mn) 4.5.4.2 Market Share by Region, 2023 & 2033 (%)
5 Biodefence Market Analysis by Region
5.1 Key Findings 5.2 Regional Segment: Market Attractiveness Index 5.3 Biodefence Market Size Estimation and Forecast
6 North America Biodefence Market Analysis
6.1 Key Findings 6.2 North America Biodefence Market Attractiveness Index 6.3 North America Biodefence Market by Country, 2023, 2028 & 2033 (US$ Mn) 6.4 North America Biodefence Market Size Estimation and Forecast by Country 6.5 North America Biodefence Market Size Estimation and Forecast by Product 6.6 U.S. Biodefence Market Analysis 6.7 Canada Biodefence Market Analysis
7 Europe Biodefence Market Analysis
7.1 Key Findings 7.2 Europe Biodefence Market Attractiveness Index 7.3 Europe Biodefence Market by Country, 2023, 2028 & 2033 (US$ Mn) 7.4 Europe Biodefence Market Size Estimation and Forecast by Country 7.5 Europe Biodefence Market Size Estimation and Forecast by Product 7.6 Germany Biodefence Market Analysis 7.7 France Biodefence Market Analysis 7.8 UK Biodefence Market Analysis 7.9 Italy Biodefence Market Analysis 7.10 Spain Biodefence Market Analysis 7.11 Russia Biodefence Market Analysis 7.12 Rest of Europe Biodefence Market Analysis
8 Asia Pacific Biodefence Market Analysis
8.1 Key Findings 8.2 Asia Pacific Biodefence Market Attractiveness Index 8.3 Asia Pacific Biodefence Market by Country, 2023, 2028 & 2033 (US$ Mn) 8.4 Asia Pacific Biodefence Market Size Estimation and Forecast by Country 8.5 Asia Pacific Biodefence Market Size Estimation and Forecast by Product 8.6 Japan Biodefence Market Analysis 8.7 China Biodefence Market Analysis 8.8 India Biodefence Market Analysis 8.9 Australia Biodefence Market Analysis 8.10 South Korea Biodefence Market Analysis 8.11 Rest of Asia Pacific Biodefence Market Analysis
9 Latin America Biodefence Market Analysis
9.1 Key Findings 9.2 Latin America Biodefence Market Attractiveness Index 9.3 Latin America Biodefence Market by Country, 2023, 2028 & 2033 (US$ Mn) 9.4 Latin America Biodefence Market Size Estimation and Forecast by Country 9.5 Latin America Biodefence Market Size Estimation and Forecast by Product 9.6 Brazil Biodefence Market Analysis 9.7 Mexico Biodefence Market Analysis 9.8 Rest of Latin America Biodefence Market Analysis
10 MEA Biodefence Market Analysis
10.1 Key Findings 10.2 MEA Biodefence Market Attractiveness Index 10.3 MEA Biodefence Market by Country, 2023, 2028 & 2033 (US$ Mn) 10.4 MEA Biodefence Market Size Estimation and Forecast by Country 10.5 MEA Biodefence Market Size Estimation and Forecast by Product 10.6 GCC Biodefence Market Analysis 10.7 South Africa Biodefence Market Analysis 10.8 Rest of MEA Biodefence Market Analysis
11 Company Profiles
11.1 Competitive Landscape, 2021 11.1.1 BioFire Defense 11.1.2 Bruker Corporation 11.1.3 Emergent BioSolutions 11.1.4 Smiths detection 11.2 Alexeter Technologies, LLC, 11.2.1 Company Snapshot 11.2.2 Company Overview 11.2.3 Product Benchmarking 11.3 Altimmune 11.3.1 Company Snapshot 11.3.2 Company Overview 11.3.3 Financial Analysis 11.3.3.1 Net Revenue, 2017-2021 11.3.3.2 R&D, 2017-2021 11.3.4 Product Benchmarking 11.4 ANP Technology 11.4.1 Company Snapshot 11.4.2 Company Overview 11.4.3 Product Benchmarking 11.5 Bavarian Nordic 11.5.1 Company Snapshot 11.5.2 Company Overview 11.5.3 Financial Analysis 11.5.3.1 Net Revenue, 2017-2021 11.5.3.2 R&D, 2017-2021 11.5.3.3 Regional Market Shares, 2021 11.5.4 Product Benchmarking 11.5.5 Strategic Outlook 11.6 Biofire Defense (bioMerieux SA) 11.6.1 Company Snapshot 11.6.2 Company Overview 11.6.3 Financial Analysis 11.6.3.1 Net Revenue, 2017-2021 11.6.3.2 R&D, 2017-2021 11.6.3.3 Regional Market Shares, 2021 11.6.4 Product Benchmarking 11.6.5 Strategic Outlook 11.7 Biosearch Technologies 11.7.1 Company Snapshot 11.7.2 Company Overview 11.7.3 Financial Analysis 11.7.3.1 Net Revenue, 2017-2021 11.7.3.2 Regional Market Shares, 2021 11.7.4 Product Benchmarking 11.8 Bruker 11.8.1 Company Snapshot 11.8.2 Company Overview 11.8.3 Financial Analysis 11.8.3.1 Net Revenue, 2017-2021 11.8.3.2 R&D, 2017-2021 11.8.3.3 Regional Market Shares, 2021 11.8.4 Product Benchmarking 11.9 Electronic Sensor Technology Inc. 11.9.1 Company Snapshot 11.9.2 Company Overview 11.9.3 Product Benchmarking 11.10 Elusys Therapeutics 11.10.1 Company Snapshot 11.10.2 Company Overview 11.10.3 Product Benchmarking 11.10.4 Strategic Outlook 11.11 Emergent BioSolutions Inc. 11.11.1 Company Snapshot 11.11.2 Company Overview 11.11.3 Financial Analysis 11.11.3.1 Net Revenue, 2017-2021 11.11.3.2 R&D, 2017-2021 11.11.4 Product Benchmarking 11.11.5 Strategic Outlook 11.12 Ichor Medical 11.12.1 Company Snapshot 11.12.2 Company Overview 11.12.3 Product Benchmarking 11.13 NanoLogix 11.13.1 Company Snapshot 11.13.2 Company Overview 11.13.3 Product Benchmarking 11.14 New Horizons Diagnostic Corporation 11.14.1 Company Snapshot 11.14.2 Company Overview 11.14.3 Product Benchmarking 11.14.4 Strategic Outlook 11.15 PositiveID Corporation 11.15.1 Company Snapshot 11.15.2 Company Overview 11.15.3 Product Benchmarking 11.16 SIGA Technologies, Inc 11.16.1 Company Snapshot 11.16.2 Company Overview 11.16.3 Financial Analysis 11.16.3.1 Net Revenue, 2017-2021 11.16.3.2 R&D, 2017-2021 11.16.4 Product Benchmarking 11.16.5 Strategic Outlook 11.17 Alnylam Pharmaceuticals 11.17.1 Company Snapshot 11.17.2 Company Overview 11.17.3 Financial Analysis 11.17.3.1 Net Revenue, 2017-2021 11.17.3.2 R&D, 2017-2021 11.17.4 Product Benchmarking 11.17.5 Strategic Outlook 11.18 BBI Detection 11.18.1 Company Snapshot 11.18.2 Company Overview 11.18.3 Product Benchmarking 11.19 Statera Biopharma 11.19.1 Company Snapshot 11.19.2 Company Overview 11.19.3 Financial Analysis 11.19.3.1 Net Revenue, 2017-2021 11.19.3.2 R&D, 2017-2021 11.19.4 Product Benchmarking 11.20 Dynport Vaccine Company 11.20.1 Company Snapshot 11.20.2 Company Overview 11.20.3 Product Benchmarking 11.21 Research International 11.21.1 Company Snapshot 11.21.2 Company Overview 11.21.3 Product Benchmarking 11.22 Smith’s Detection 11.22.1 Company Snapshot 11.22.2 Company Overview 11.22.3 Product Benchmarking 11.22.4 Strategic Outlook 11.23 Synexis Systems 11.23.1 Company Snapshot 11.23.2 Company Overview 11.23.3 Product Benchmarking 11.23.4 Strategic Outlook
12 Conclusion and Recommendations
12.1 Concluding Remarks from 12.2 Recommendations for Market Players
Companies Mentioned
Alexeter Technologies, LLC,
Altimmune
Achaogen, Inc.
Alnylam Pharmaceuticals
ANP Technology
Bavarian Nordic
BBI Detection
Biofire Defense (bioMerieux SA)
Biosearch Technologies
Bruker
Dynport Vaccine Company
Electronic Sensor Technology Inc.
Elusys Therapeutics
Emergent BioSolutions Inc.
Ichor Medical
NanoLogix
New Horizons Diagnostic Corporation
PositiveID Corporation
Research International
SIGA Technologies, Inc.
Statera Biopharma (Cleveland Biolabs)
Smith’s Detection
Synexis Systems
AbCellera
AstraZeneca
Banbury Labels
Canopy Biosciences, LLC
Chimerix, Inc.
Coeptis Therapeutics, Inc
Cytocom
Dynavax Technologies Corporation
Encepur
Ensensor
Fulgent Pharma
Heat Biologics, Inc.
Kromek
Medison Pharma
MOLECUBES NV,
Neurescence Inc.
Novartis
Optimal Industrial Automation and Technologies
PeptiDream
PharmAthene
Prolab Instruments GmbH
RAVE LLC
Regeneron
Stratus
Valneva SE
Vaxart, Inc.
American Biological Safety Association
American Society for Microbiology
Arms Control Association
Asia-Pacific Biosafety Association (APBA)
Biomedical Advanced Research and Development Authority (BARDA)
Biorisk Management Association of Kenya (BMAK)
Biosafety and Biosecurity Association of South Sudan (BBASS)
Canadian Association for Biological Safety
European Agency for the Evaluation of Medicinal Products
European Corporate Security Association (ECSA)
Georgian Biosafety Association (GeBSA)
German Biosecurity Programme
Infectious Disease Society of America
Korean Biological Safety Association
Malaysian Biosafety & Biosecurity Association
Mali Association for Biosafety & Biosecurity
Mexican Biosafety Association (AMEXBIO)
National Biosafety Association (ANBio)
National Institute of Allergy and Infectious Diseases (NIAID)
Nigerian Biological Safety Association (NiBSA)
Office of International Health and Biodefense (IHB)
This product is a market research report. Each license type allows a set number of users to access the report. Please select an option from the list below. This product is a market research report. This is a single user license, allowing one user access to the product. The product is a PDF. This product is a market research report. This is a 1-5 user license, allowing up to five users have access to the product. The product is a PDF. This product is a market research report. This is a site license, allowing all users within a given geographical location of your organization access to the product. The product is a PDF. This product is a market research report. This is an enterprise license, allowing all employees within your organization access to the product. The product is a PDF.
The sample excerpt is provided to help you make an informed purchasing decision. It is not intended to serve as free content or replace a full report. To ensure the sample aligns with your specific needs, our team will contact you to better understand your requirements.
An error occurred while sending the message. Should this issue persist, email us at help@researchandmarkets.net
This report can be tailored to focus on a specific country, region, continent, or provide global coverage. Please indicate your regions of interest and share any additional questions you may have. Our team strives to respond to all inquiries within the same business day.
An error occurred while sending the message. Should this issue persist, email us at help@researchandmarkets.net